PE/Cyanine7 anti-human CD105 Antibody
- 产品名称：
- PE/Cyanine7 anti-human CD105 Antibody
- 产品类别：
- 抗体
- 产品编号：
- 323217
- 产品应用：
- 323217
[价格]
| 规格 |
价格 |
库存 |
| 25tests |
￥ 1764 |
1 |
- Verified Reactivity
- Human
- Antibody Type
- Monoclonal
- Host Species
- Mouse
- Immunogen
- L-cells transfected with human CD105
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
- Preparation
- The antibody was purified by affinity chromatography and conjugated with PE/Cyanine7 under optimal conditions.
- Concentration
- Lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
FC - Quality tested
- Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 ?l per million cells in 100 ?l staining volume or 5 ?l per 100 ?l of whole blood.
- Excitation Laser
- Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
- Additional Product Notes
- BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.
- Application References
(PubMed link indicates BioLegend citation) -
- Bühring HJ, et al. 1991. Leukemia 5:841.
- Vogel W, et al. 2002. Haematologica 88:126.
- Osaka M, et al. 2011. Brain Res. 9:1343. PubMed
- HonMou O, et al. 2011. Brain. 134:1790. PubMed
- Herrera MB, et al. 2013. Hepatology. 57:311. PubMed
- Iohara K, et al. 2014. Exp Gerontol. 52:39. PubMed
- Product Citations
-
- Jungwirth N et al. 2018. Journal of molecular neuroscience : MN. 65(1):60-73 . PubMed
- Busch A, et al. 2020. Int J Mol Sci. 21:. PubMed
- Boucher JM, et al. 2018. Cardiovasc Drugs Ther. 32:519. PubMed
- Kim JM, et al. 2020. Nat Commun. 11:2289. PubMed
- Brandau S, et al. 2014. PLoS One. 9:106903. PubMed
- RRID
- AB_10895769 (BioLegend Cat. No. 323217) AB_10900820 (BioLegend Cat. No. 323218)
- Structure
- Associates with TGF-? receptor I and II, homodimeric type I integral membrane protein, 90 kD
- Distribution
-
Endothelial cells, activated monocytes/macrophages, bone marrow stromal cells, hematopoietic stem/progenitor cells
- Function
- Modulates cellular response to TGF-?, involved in vascular development and remodelling
- Ligand/Receptor
- TGF-?1, TGF-?3
- Cell Type
- Endothelial cells, Hematopoietic stem and progenitors, Macrophages, Mesenchymal Stem Cells, Monocytes
- Biology Area
- Angiogenesis, Cell Biology, Immunology, Stem Cells
- Molecular Family
- Adhesion Molecules, CD Molecules
- Antigen References
-
1. Mason D, et al. Eds. 2002. Leucocyte Typing VII. Oxford University Press. New York.
2. Pierelli L, et al. 2001. Leuk. Lymphoma 42:1195.
- Gene ID
- 2022 View all products for this Gene ID
- UniProt
- View information about CD105 on UniProt.org
